Drugs / Buprenorphine/naloxone
last change Sep 2008 re-read 2 minutes ago

Buprenorphine/naloxone

Developed for
opiate dependence
Investigated by
Indivior Inc.

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00637000 Mar → Sep 2008 opiate dependence Indivior Inc. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Buprenorphine/naloxone ClinicalTrials.gov intervention name — accepted as the source's own label NCT00637000